Aberdeen Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276M | Sell |
|
|||||
|
2025
Q1 | $284M | Buy |
|
|||||
|
2024
Q4 | $234M | Sell |
|
|||||
|
2024
Q3 | $244M | Sell |
|
|||||
|
2024
Q2 | $247M | Sell |
|
|||||
|
2024
Q1 | $238M | Sell |
|
|||||
|
2023
Q4 | $209M | Sell |
|
|||||
|
2023
Q3 | $355M | Sell |
|
|||||
|
2023
Q2 | $421M | Sell |
|
|||||
|
2023
Q1 | $393M | Buy |
|
|||||
|
2022
Q4 | $352M | Sell |
|
|||||
|
2022
Q3 | $309M | Sell |
|
|||||
|
2022
Q2 | $315M | Sell |
|
|||||
|
2022
Q1 | $391M | Sell |
|
|||||
|
2021
Q4 | $384M | Buy |
|
|||||
|
2021
Q3 | $392M | Sell |
|
|||||
|
2021
Q2 | $404M | Sell |
|
|||||
|
2021
Q1 | $378M | Buy |
|
|||||
|
2020
Q4 | $332M | Sell |
|
|||||
|
2020
Q3 | $375M | Buy |
|
|||||
|
2020
Q2 | $341M | Buy |
|
|||||
|
2020
Q1 | $295M | Buy |
|
|||||
|
2019
Q4 | $356M | Buy |
|
|||||
|
2019
Q3 | $314M | Sell |
|
|||||
|
2019
Q2 | $345M | Buy |
|
|||||
|
2019
Q1 | $296M | Sell |
|
|||||
|
2018
Q4 | $321M | Sell |
|
|||||
|
2018
Q3 | $466M | Sell |
|
|||||
|
2018
Q2 | $458M | Buy |
|
|||||
|
2018
Q1 | $378M | Buy |
|
|||||
|
2017
Q4 | $312M | Sell |
|
|||||
|
2017
Q3 | $370M | Buy |
|